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Fas/FasL-mediated apoptosis is crucial for a functional
immune response, with deficient Fas/FasL expression
being linked to several autoimmune diseases. In addition,
a FAS-670 polymorphism in an interferon (IFN)-regulated
STAT1-binding site has been associated to both ATL
(Farre et al., 2008) and HAM/TSP (Vallinotto et al., 2012)
susceptibility. Recently, Fas has also been identified as part
of an IFN-regulated gene signature in HAM/TSP (Tatter-
musch et al., 2012). Therefore, we examined Fas expres-
sion and function in lymphocyte activation, apoptosis,
lymphoproliferation and gene expression profiling, using
polychromatic flow cytometry, thymidine incorporation
and microarray analysis (Affymetrix) respectively, in
PBMCs from 20 HAM/TSP patients, 30 asymptomatic
HTLV-1-infected individuals and 34 healthy controls
(Salvador-Bahia, Brazil). Fas expression was increased in
both asymptomatic HTLV-1-infected individuals and
HAM/TSP patients, as compared to uninfected controls.
In HAM/TSP, Fas expression correlated positively to lym-
phocyte activation markers (HLA-DR, CD86), but nega-
tively to disease duration, suggesting that Fas-mediated
pro-apoptotic capacity decreases over time in patients.
Likewise, increased Fas expression in HAM/TSP did
not lead to increased apoptosis upon in vitro culture.
However, in HAM/TSP patients, IFN-alpha-induced
Fas expression was paralleled by decreased lymphoproli-
feration, suggesting a link between defective Fas-mediated
apoptosis and excessive lymphoproliferation, a hallmark of
HTLV-1 infection, which can be restored by IFN-alpha
treatment. Taken together, our results suggest defective
Fas-mediated apoptosis might be an additional factor of
HAM/TSP pathogenesis, besides its recently identified
IFN gene signature.
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